Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elise Konradsson has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Initial Evaluation of Feasibility and Cutaneous Toxicity of Electron FLASH Radiotherapy Using a Standard-of-Care Fractionation Scheme in a Porcine Skin Model

    by Elise Konradsson, Kevin Liu, Safee Baig, Susanne Je-Han Lin, Alan Hernandez Lopez, Brett Velasquez, Stephanie Mayor, Kayla Samuel, Traci Viscarra, Krystal Garrow, et al.

    Background/Objectives: FLASH radiotherapy (RT) has shown potential to reduce normal tissue toxicity compared with conventional (CONV) RT while maintaining tumor control. FLASH RT is characterized by ultra-high dose rate delivery, commonly using mean dose rates ≥ 40 Gy/s and sub-second delivery times. Most preclinical studies have used single-fraction regimens, leaving the feasibility and normal tissue impact of clinically relevant fractionation largely unexplored. We evaluated electron FLASH RT given in a standard five-fraction regimen to a porcine skin model, simulating adjuvant treatment workflow for high-risk cutaneous melanoma. Method: Three Yorkshire–Landrace swine received paired five-fraction electron irradiations to dorsolateral skin using either FLASH RT (mean dose rates 175–246 Gy/s) or CONV RT (8 Gy/min). Radiation was delivered with a 9-MeV electron beam; field diameters of 4, 7, or 10 cm; and doses of 5 × 6, 5 × 7, or 5 × 8 Gy. Dosimetry was validated with several dosimeters and real-time beam monitoring, confirming dose accuracy within 3%. Skin toxicity was assessed over 22–24 weeks using clinical grading, erythema spectrophotometry, and histopathologic evaluation. Results: FLASH RT was well tolerated at 5 × 6 Gy and 5 × 7 Gy, with no significant differences in peak radiation dermatitis, erythema index, or histologic damage compared with CONV RT. At 5 × 8 Gy, both modalities caused unacceptable toxicity, including moist desquamation and necrosis. No volume-dependent effects were observed. Conclusions: Although a FLASH-specific normal tissue sparing effect was not observed, this study demonstrates the technical feasibility and safety of delivering fractionated electron FLASH RT in a large animal model using a clinically relevant workflow. These findings support further investigation of physical beam parameters and biological modifiers, such as tissue oxygenation, and inform the clinical translation of fractionated FLASH RT for cutaneous malignancies.

  • Open Access

    Long-term Musculoskeletal and Marrow Sparing with Proton FLASH in Juvenile Mice: Implications for Pediatric Osteosarcoma

    by Zongsheng Hu, Uwe Titt, Yuting Li, Elise Konradsson, Edgardo A Aguilar, Denae W Neill, Luke Connell, Xiaochun Wang, Henry James Meyer, Mihai Lurascu Gagea, et al.

    Purpose: Osteosarcoma is the most common primary bone malignancy in children and adolescents. Radiotherapy is limited by intrinsic radioresistance and the risk of severe long-term musculoskeletal toxicities. FLASH radiotherapy, delivered at ultra-high dose rates (>40 Gy/s), has demonstrated normal tissue sparing in preclinical models, but its effects on the developing skeleton and marrow remain poorly defined. This study evaluated the chronic normal tissue effects of proton FLASH in juvenile mice, modeling the pediatric context. Methods and Materials: Juvenile C57BL/6 mice (3–4 weeks old) were randomized to receive 11 Gy FLASH (≈200 Gy/s) or conventional proton irradiation (0.2 Gy/s average), or sham treatment to the left hind leg using a synchrotron-based proton beamline. Mice were followed for 10 weeks post-treatment. Bone toxicity was assessed with microCT (bone mineral density, bone volume fractions, trabecular indices) and histology. Bone marrow cellularity was quantified on H&E-stained sections, and muscle fibrosis was assessed using Masson’s trichrome. Results: FLASH-treated mice exhibited significant preservation of bone microarchitecture compared with conventional treated mice, with higher bone mineral density and bone volume fractions (p < 0.05). Trabecular numbers were maintained, while structure model index indicates a mechanically favorable trabecular structures in the FLASH group. Bone marrow cellularity was preserved in FLASH mice (5.3% reduction vs. sham) compared with conventional (11.3 % reduction, p < 0.05). Muscle fibrosis was significantly lower in FLASH group (fibrosis positivity 2.6 % vs. 3.0% for FLASH vs. conventional CONV, p < 0.05). No severe immobility or weight loss was observed across groups. Conclusions: Proton FLASH significantly reduces long-term bone, marrow, and muscle toxicities in juvenile mice. These findings provide the first demonstration of musculoskeletal sparing in a synchrotron proton FLASH platform and highlight its translational potential for pediatric osteosarcoma.


  • Open Access

    Aberrant Neuronal Synchronization Associated with Cognitive Deficits in a Rodent Model of Childhood Cranial Irradiation

    by Sebastian A. Barrientos, Elise Konradsson, Crister Ceberg, Per Petersson

    Cranial radiation can be a life-saving intervention in pediatric brain cancer therapy but often results in debilitating cognitive decline. To clarify the underlying mechanisms of these side-effects we have here recorded neurophysiological activity in distributed brain networks involved in decision-making and memory functions in adult rats exposed to cranial irradiation on postnatal day 21. Multi-structure local field potential (LFP) recordings revealed decreased power in irradiated animals in the 4-9 Hz frequency band. Additionally, a distinct slowing of the oscillatory activity was observed preceding erroneous choice in a decision-making task. Moreover, irradiated rats showed reduced dynamics and a fragmented pattern of inter-structural coherence across different phases of the task. Our results suggest that the cognitive deficits and reduced processing speed following irradiation of the juvenile brain arise as a consequence of changes in long-range functional connectivity, including thalamocortical circuits, causing abnormally slow and spatially fractionated patterns of coordinating LFP activity.

  • Reconfiguring a Plane-Parallel Transmission Ionization Chamber to Extend the Operating Range into the Ultra-High Dose-per-pulse Regime

    by Elise Konradsson, Rebecka Ericsson Szecsenyi, Pontus Wahlqvist, Andreas Thoft, Börje Blad, Sven Åj Bäck, Crister Ceberg, Kristoffer Petersson

    This study aims to investigate the feasibility of enhancing the charge collection efficiency (CCE) of a transmission chamber by reconfiguring its design and operation. The goal was to extend the range of dose-per-pulse (DPP) values with no or minimal recombination effects up to the ultra-high dose rate (UHDR) regime. The response of two transmission chambers, with electrode distance of 1 mm and 0.6 mm, respectively, was investigated as a function of applied voltage. The chambers were mounted one-by-one in the electron applicator of a 10 MeV FLASH-modified clinical linear accelerator. The chamber signals were measured as a function of nominal DPP, which was determined at the depth of dose maximum using EBT-XD film in solid water and ranged from 0.6 mGy per pulse to 0.9 Gy per pulse, for both the standard voltage of 320 V and the highest possible safe voltage of 1,200 V. The CCE was calculated and fitted with an empirical logistic function that incorporated the electrode distance and the chamber voltage. The CCE decreased with increased DPP. The CCE at the highest achievable DPP was 24% (36%) at 320 V and 51% (82%) at 1,200 V, for chambers with 1 mm (0.6 mm) electrode distance. For the combination of 1,200 V- and 0.6-mm electrode distance, the CCE was ∼100% for average dose rate up to 70 Gy/s at the depth of dose maximum in the phantom at a source-to-surface distance of 100 cm. Our findings indicate that minor modifications to a plane-parallel transmission chamber can substantially enhance the CCE and extending the chamber's operating range to the UHDR regime. This supports the potential of using transmission chamber-based monitoring solutions for UHDR beams, which could facilitate the delivery of UHDR treatments using an approach similar to conventional clinical delivery.


  • Open Access

    Polymer gel dosimetry for experimental verification of conformal small animal irradiation at a preclinical research platform

    by E Konradsson, M Blomstedt, C Jamtheim Gustafsson, S Å J Bäck, C Ceberg, S Ceberg

    In translational research, there is a need for preclinical studies of high quality that corresponds to the conformal dose distributions conventionally delivered to humans in the modern radiotherapy clinic. To facilitate this need, novel preclinical systems consist of preclinical radiation platforms and small animal treatment planning systems. However, small-field dosimetry is challenging and requires dosimeters with high spatial resolution. In this study we demonstrate the feasibility of experimentally validating the dose distribution in small fields at a preclinical X-ray research platform using a polymer gel dosimeter and MRI-readout.

  • Open Access

    Evaluation of intensity‐modulated electron FLASH radiotherapy in a clinical setting using veterinary cases

    by Elise Konradsson, Rebecka Ericsson Szecsenyi, Gabriel Adrian, Mizgin Coskun, Betina Børresen, Maja Louise Arendt, Kevin Erhart, Sven Åj Bäck, Kristoffer Petersson, Crister Ceberg

    Purpose: The increased normal tissue tolerance for FLASH radiotherapy (FLASH‐RT), as compared to conventional radiotherapy, was first observed in ultra‐high dose rate electron beams. Initial clinical trials in companion animals have revealed a high risk of developing osteoradionecrosis following high‐dose single‐fraction electron FLASH‐RT, which may be related to inhomogeneities in the dose distribution. In the current study, we aim to evaluate the possibilities of intensity‐modulated electron FLASH‐RT in a clinical setting to ensure a homogeneous dose distribution in future veterinary and human clinical trials.Methods: Our beam model in the treatment planning system electronRT (.decimal, LLC, Sanford, FL, USA) was based on a 10‐MeV electron beam from a clinical linear accelerator used to treat veterinary patients with FLASH‐RT in a clinical setting. In electronRT, the beam can be intensity‐modulated using tungsten island blocks in the electron block cutout, and range‐modulated using a customized bolus with variable thickness. Modulations were first validated in a heterogeneous phantom by comparing measured and calculated dose distributions. To evaluate the impact of intensity modulation in superficial single‐fraction FLASH‐RT, a treatment planning study was conducted, including eight canine cancer patient cases with simulated tumors in the head‐and‐neck region. For each case, treatment plans with and without intensity modulation were created for a uniform bolus and a range‐modulating bolus. Treatment plans were evaluated using a target dose homogeneity index (HI), a conformity index (CI), the near‐maximum dose outside the target (), and the near‐minimum dose to the target ().Results: By adding intensity modulation to plans with a uniform bolus, the HI could be improved (p = 0.017). The combination of a range‐modulating bolus and intensity modulation provided a further significant improvement of the HI as compared to using intensity modulation in combination with a uniform bolus (p = 0.036). The range‐modulating bolus also improved the CI compared to using a uniform bolus, both with an open beam (p = 0.046) and with intensity modulation (p = 0.018), as well as increased the (p = 0.036 with open beam and p = 0.05 with intensity modulation) and reduced the median (not significant).Conclusions: By using intensity‐modulated electron FLASH‐RT in combination with range‐modulating bolus, the target dose homogeneity and conformity in canine patients with simulated tumors in complex areas in the head‐and‐neck region could be improved. By utilizing this technique, we hope to decrease the dose outside the target volume and avoid hot spots in future clinical electron FLASH‐RT studies, thereby reducing the risk of radiation‐induced toxicity.


  • Open Access

    Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients

    by Betina Børresen, Maja L. Arendt, Elise Konradsson, Kristine Bastholm Jensen, Sven Åj. Bäck, Per Munck Af Rosenschöld, Crister Ceberg, Kristoffer Petersson

    Background: FLASH radiotherapy (RT) is a novel method for delivering ionizing radiation, which has been shown in preclinical studies to have a normal tissue sparing effect and to maintain anticancer efficacy as compared to conventional RT. Treatment of head and neck tumors with conventional RT is commonly associated with severe toxicity, hence the normal tissue sparing effect of FLASH RT potentially makes it especially advantageous for treating oral tumors. In this work, the objective was to study the adverse effects of dogs with spontaneous oral tumors treated with FLASH RT.Methods: Privately-owned dogs with macroscopic malignant tumors of the oral cavity were treated with a single fraction of ≥30Gy electron FLASH RT and subsequently followed for 12 months. A modified conventional linear accelerator was used to deliver the FLASH RT.Results: Eleven dogs were enrolled in this prospective study. High grade adverse effects were common, especially if bone was included in the treatment field. Four out of six dogs, who had bone in their treatment field and lived at least 5 months after RT, developed osteoradionecrosis at 3-12 months post treatment. The treatment was overall effective with 8/11 complete clinical responses and 3/11 partial responses.Conclusion: This study shows that single-fraction high dose FLASH RT was generally effective in this mixed group of malignant oral tumors, but the risk of osteoradionecrosis is a serious clinical concern. It is possible that the risk of osteonecrosis can be mitigated through fractionation and improved dose conformity, which needs to be addressed before moving forward with clinical trials in human cancer patients.


  • Open Access

    Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model

    by Elise Konradsson, Emma Liljedahl, Emma Gustafsson, Gabriel Adrian, Sarah Beyer, Suhayb Ehsaan Ilaahi, Kristoffer Petersson, Crister Ceberg, Henrietta Nittby Redebrandt


  • FLASH Mechanisms Track (Oral Presentations) FLASH SPARING OF MELANOMA CELLS IN VITRO AND IN VIVO

    by G. Adrian, A. Brus, E. Konradsson, S. Eriksson, T. Andresen, K. Petersson, A. Carneiro, A. Hansen, C. Ceberg